Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A to prevent incisional hernia after midline laparotomy
IRCT20260610069735N1Phase 2Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of botulinum toxin type A in incisional hernia (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Incidence of incisional hernia and Safety of botulinum toxin type A injection. Started Aug 2026; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
incisional hernia
Beyond the preview
Go deeper on IRCT20260610069735N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260610069735N1.